Literature DB >> 21594992

Further evidence for a marfanoid syndrome with neonatal progeroid features and severe generalized lipodystrophy due to frameshift mutations near the 3' end of the FBN1 gene.

Jack Goldblatt1, Jill Hyatt, Caitlin Edwards, Ian Walpole.   

Abstract

We report on a 20-year-old man who presented in infancy with severe generalized lipodystrophy with a progeroid appearance and some Marfanoid features. He subsequently was diagnosed with bilateral lens subluxations at the age of 16 years which prompted analysis of the FBN1 gene. This analysis showed him to have a novel heterozygous, de novo, c.8156_8175del, p.Lys2719ThrfsX12, frameshift mutation in exon 64 of his FBN1 gene. His phenotype is similar to a patient described by Graul-Neumann et al. [2010] who was found to have a de novo, heterozygous, c.8155_8156del deletion in exon 64 of FBN1. Both mutations result in a truncated protein with an extremely charged C-terminus, containing two positive and four negative charges in the last eight amino acids. This most likely has a profound impact on protein–protein interactions, which are very important in the extracellular matrix. The similarities in the phenotypes, and overlapping molecular defects, provides further evidence that the phenotype with features of Marfan syndrome with neonatal progeroid syndrome-like lipodystrophy is a distinct clinical entity due to frameshift mutations in exon 64 of the FBN1 gene.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21594992     DOI: 10.1002/ajmg.a.33906

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  11 in total

Review 1.  Marfanoid-progeroid-lipodystrophy syndrome: a newly recognized fibrillinopathy.

Authors:  Eberhard Passarge; Peter N Robinson; Luitgard M Graul-Neumann
Journal:  Eur J Hum Genet       Date:  2016-02-10       Impact factor: 4.246

2.  Bi-allelic POLR3A Loss-of-Function Variants Cause Autosomal-Recessive Wiedemann-Rautenstrauch Syndrome.

Authors:  Jennifer A Wambach; Daniel J Wegner; Nivedita Patni; Martin Kircher; Marcia C Willing; Dustin Baldridge; Chao Xing; Anil K Agarwal; Samantha A Schrier Vergano; Chirag Patel; Dorothy K Grange; Amy Kenney; Tasnim Najaf; Deborah A Nickerson; Michael J Bamshad; F Sessions Cole; Abhimanyu Garg
Journal:  Am J Hum Genet       Date:  2018-11-07       Impact factor: 11.025

3.  Asprosin, a Fasting-Induced Glucogenic Protein Hormone.

Authors:  Chase Romere; Clemens Duerrschmid; Juan Bournat; Petra Constable; Mahim Jain; Fan Xia; Pradip K Saha; Maria Del Solar; Bokai Zhu; Brian York; Poonam Sarkar; David A Rendon; M Waleed Gaber; Scott A LeMaire; Joseph S Coselli; Dianna M Milewicz; V Reid Sutton; Nancy F Butte; David D Moore; Atul R Chopra
Journal:  Cell       Date:  2016-04-14       Impact factor: 41.582

Review 4.  Asprosin, a C-Terminal Cleavage Product of Fibrillin 1 Encoded by the FBN1 Gene, in Health and Disease.

Authors:  Mehmet Akif Ovali; Ibrahim Bozgeyik
Journal:  Mol Syndromol       Date:  2022-02-08

Review 5.  Energy Regulation Mechanism and Therapeutic Potential of Asprosin.

Authors:  Jennifer G Hoffmann; Wei Xie; Atul R Chopra
Journal:  Diabetes       Date:  2020-04       Impact factor: 9.461

6.  Truncated C-terminus of fibrillin-1 induces Marfanoid-progeroid-lipodystrophy (MPL) syndrome in rabbit.

Authors:  Mao Chen; Bing Yao; Qiangbing Yang; Jichao Deng; Yuning Song; Tingting Sui; Lina Zhou; HaoBing Yao; Yuanyuan Xu; Hongsheng Ouyang; Daxin Pang; Zhanjun Li; Liangxue Lai
Journal:  Dis Model Mech       Date:  2018-04-09       Impact factor: 5.758

7.  Genetic and molecular mechanism for distinct clinical phenotypes conveyed by allelic truncating mutations implicated in FBN1.

Authors:  Mao Lin; Zhenlei Liu; Gang Liu; Sen Zhao; Chao Li; Weisheng Chen; Zeynep Coban Akdemir; Jiachen Lin; Xiaofei Song; Shengru Wang; Qiming Xu; Yanxue Zhao; Lianlei Wang; Yuanqiang Zhang; Zihui Yan; Sen Liu; Jiaqi Liu; Yixin Chen; Yuzhi Zuo; Xu Yang; Tianshu Sun; Xin-Zhuang Yang; Yuchen Niu; Xiaoxin Li; Wesley You; Bintao Qiu; Chen Ding; Pengfei Liu; Shuyang Zhang; Claudia M B Carvalho; Jennifer E Posey; Guixing Qiu; James R Lupski; Zhihong Wu; Jianguo Zhang; Nan Wu
Journal:  Mol Genet Genomic Med       Date:  2019-11-27       Impact factor: 2.183

8.  C-terminal propeptide is required for fibrillin-1 secretion and blocks premature assembly through linkage to domains cbEGF41-43.

Authors:  Sacha A Jensen; Georgia Aspinall; Penny A Handford
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-30       Impact factor: 11.205

9.  A trans-acting protein effect causes severe eye malformation in the Mp mouse.

Authors:  Joe Rainger; Margaret Keighren; Douglas R Keene; Noe L Charbonneau; Jacqueline K Rainger; Malcolm Fisher; Sebastien Mella; Jeffrey T-J Huang; Lorraine Rose; Rob van't Hof; Lynne Y Sakai; Ian J Jackson; David R Fitzpatrick
Journal:  PLoS Genet       Date:  2013-12-12       Impact factor: 5.917

10.  Expression of FBN1 during adipogenesis: Relevance to the lipodystrophy phenotype in Marfan syndrome and related conditions.

Authors:  Margaret R Davis; Erik Arner; Cairnan R E Duffy; Paul A De Sousa; Ingrid Dahlman; Peter Arner; Kim M Summers
Journal:  Mol Genet Metab       Date:  2016-06-23       Impact factor: 4.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.